NCT02697994

Brief Summary

ABSTRACT Introduction: In addition to pain caused by uterine contractions in labour, in 33% of women, continuous and severe back pain is observed. In management of this pain, sterile water injection is considered to be an effective method. Aim of this study is assessment of effectiveness and satisfaction of this method among Turkish women in which analgesic methods are not extensively used in labour and rates of cesarean section exponentially increases. Material and Methods: 168 termed, healthy women who admitted to Istanbul Gaziosmanpaşa-Taksim Training and Research Hospital with labour pain and had severe back pain were randomized into 4x0.1 ml sterile water and 4xdry Injection groups. Injections were applied to Michaelis Rhomboid region in sacral region. Pain scores were assessed at 10th, 30th, 60th, 120th and 180th minutes with Visual Analog Scale (VAS). Additionally, need for epidural analgesia, APGAR score, mode of delivery, time of delivery, maternal satisfaction and breastfeeding scores were assessed.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2016

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
Last Updated

March 3, 2016

Status Verified

February 1, 2016

Enrollment Period

9 months

First QC Date

February 9, 2016

Last Update Submit

March 2, 2016

Conditions

Keywords

Sterile Water InjectionMidwifery

Outcome Measures

Primary Outcomes (1)

  • Pain scores-30

    In pain scoring Visual Analog Scale was used

    at 30 mins after interventions

Secondary Outcomes (9)

  • Pain scores-10

    at 10 mins after interventions

  • Pain scores-60

    at 60 mins after interventions

  • Pain scores-90

    at 90 mins after interventions

  • Pain scores-120

    at 120 mins after interventions

  • Pain scores-180

    at 180 mins after interventions

  • +4 more secondary outcomes

Study Arms (2)

Sterile Water Injection

EXPERIMENTAL

Participants randomised to the intervention group received 4 intracutaneous injections of 0.1 ml sterile water into the skin surrounding the Michaelis rhomboid over the sacral area.

Other: Sterile Water

Dry Injection

PLACEBO COMPARATOR

Participants in the control group received 4 dry injections in the same region using an insulin needle .

Other: Dry Injections

Interventions

0.1 ml intracutaneous sterile water injections into the skin surrounding the Michaelis rhomboid over the sacral area.

Sterile Water Injection

dry injections into the skin surrounding the Michaelis rhomboid over the sacral area.

Dry Injection

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged between 18-35
  • weeks of gestation
  • Expecting vaginal delivery
  • Cephalic presentation
  • Single, healthy fetus
  • Spontaneous onset of labor
  • Active phase of first stage of labor (3-7 cm cervical dilatation)
  • Severe low back pain (VAS\>7cm)
  • Required pain relief

You may not qualify if:

  • Gestation \<37 weeks
  • Multiple pregnancy
  • Malpresentation
  • Second stage labour
  • Pharmacological analgesia prior to SWI
  • Back pain assessed by VAS \<7
  • Women whose labour would be considered high risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Labor PainBack Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assist.prof.

Study Record Dates

First Submitted

February 9, 2016

First Posted

March 3, 2016

Study Start

June 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

March 3, 2016

Record last verified: 2016-02